IDIOPATHIC PULMONARY FIBROSIS (IPF)
Clinical trials for IDIOPATHIC PULMONARY FIBROSIS (IPF) explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC PULMONARY FIBROSIS (IPF) trials appear
Sign up with your email to follow new studies for IDIOPATHIC PULMONARY FIBROSIS (IPF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill for scarred lungs shows promise in early trial
Disease control CompletedThis study tested an experimental oral drug called INS018_055 in 71 adults with idiopathic pulmonary fibrosis (IPF), a lung disease that causes scarring and breathing difficulty. The main goal was to check safety and tolerability over 12 weeks, comparing the drug to a placebo. Re…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS (IPF)
Phase: PHASE2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated May 17, 2026 06:49 UTC
-
New study links arm exercise test to quality of life in lung disease patients
Knowledge-focused CompletedThis study looked at 21 adults with idiopathic pulmonary fibrosis (IPF) to see how a 6-minute arm test (moving rings between pegs) relates to other measures like walking distance, sit-to-stand ability, fatigue, and quality of life. Researchers aimed to find simple ways to track h…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS (IPF)
Sponsor: Marmara University • Aim: Knowledge-focused
Last updated May 17, 2026 06:52 UTC
-
Hidden muscle loss linked to worse lung disease outcomes
Knowledge-focused CompletedThis study looked at 60 people with idiopathic pulmonary fibrosis (IPF), a serious lung disease, to see how muscle loss (sarcopenia) impacts their quality of life and disease progression. Researchers measured muscle strength, walking speed, and lung function, and found that muscl…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS (IPF)
Sponsor: Mersin University • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC